CNS prophylaxis in aggressive lymphomas: for whom and how

被引：1

作者：

Benevolo, Giulia ^{[1
]}

Chiappella, Annalisa ^{[1
]}

Vitolo, Umberto ^{[1
]}

机构：

[1] Citta Salute & Sci Hosp, Turin, Italy

来源：

HEMATOLOGICAL ONCOLOGY | 2013年 / 31卷

关键词：

Central nervous system; aggressive lymphoma; intrathecal chemotherapy; risk factors; rituximab; B-CELL LYMPHOMA; ELDERLY-PATIENTS; RISK-FACTORS; RITUXIMAB; RELAPSE; TESTIS; TRIAL;

D O I：

10.1002/hon.2074

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：89 / 91

页数：3

共 15 条

[1] Double-hit B-cell lymphomas [J].

Aukema, Sietse M. ;

Siebert, Reiner ;

Schuuring, Ed ;

van Imhoff, Gustaaf W. ;

Kluin-Nelemans, Hanneke C. ;

Boerma, Evert-Jan ;

Kluin, Philip M. .

BLOOD, 2011, 117 (08) :2319-2331

[2]

Barosi G, 2006, HAEMATOLOGICA, V91, P96

[3] Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination [J].

Benevolo, Giulia ;

Stacchini, Alessandra ;

Spina, Michele ;

Ferreri, Andres J. M. ;

Arras, Marcella ;

Bellio, Laura ;

Botto, Barbara ;

Bulian, Pietro ;

Cantonetti, Maria ;

Depaoli, Lorella ;

Di Renzo, Nicola ;

Di Rocco, Alice ;

Evangelista, Andrea ;

Franceschetti, Silvia ;

Godio, Laura ;

Mannelli, Francesco ;

Pavone, Vincenzo ;

Pioltelli, Pietro ;

Vitolo, Umberto ;

Pogliani, Enrico M. .

BLOOD, 2012, 120 (16) :3222-3228

[4] Diagnosis and treatment of central nervous system involvement in non-Hodgkin's Lymphoma [J].

Bierman, P ;

Giglio, P .

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (04) :597-+

[5] CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL) [J].

Boehme, Volkmar ;

Schmitz, Norbert ;

Zeynalova, Samira ;

Loeffler, Markus ;

Pfreundschuh, Michael .

BLOOD, 2009, 113 (17) :3896-3902

[6]

Conconi A, 2013, LEUKEMIA LYMPHOMA, P1

[7]

Dreyling M, 2012, LEUKEMIA LYMPHOMA, P1

[8] Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab [J].

Feugier, P ;

Virion, JM ;

Tilly, H ;

Haioun, C ;

Marit, G ;

Macro, M ;

Bordessoule, D ;

Recher, C ;

Blanc, M ;

Molina, T ;

Lederlin, P ;

Coiffier, B .

ANNALS OF ONCOLOGY, 2004, 15 (01) :129-133

[9] How I treat mantle cell lymphoma [J].

Ghielmini, Michele ;

Zucca, Emanuele .

BLOOD, 2009, 114 (08) :1469-1476

[10] Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature [J].

Guirguis, Hany R. ;

Cheung, Matthew C. ;

Mahrous, Mervat ;

Piliotis, Eugenia ;

Berinstein, Neil ;

Imrie, Kevin R. ;

Zhang, Liying ;

Buckstein, Rena .

BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (01) :39-49

← 1 2 →